Dr. Kevin Kelleher:

We may need to come back to the debate on one big issue which is the confidence in vaccines but more specifically, we have had considerable consultation with the Department of Education and Skills and the education bodies such as the unions, the parents' associations, school management bodies and so on, so we have done a lot of work there. I take up the point quite keenly about the young innovators. My daughter was in the final six or seven years ago.

It is something we could look at trying to get involved in and I thank the committee for the promotion.

With regard to Brexit, the UK already has different immunisation policies to us. There are variations, and the committee has heard we give hepatitis B vaccinations at birth while the UK does not. It has a programme for shingles for the elderly and we do not have this. It has changed its programme on the flu to being very much more concentrated on children. Clearly this is something we will have to do because it is beginning to show quite major success as a consequence. There are some differences but, having said that, it is very difficult to have total uniformity throughout Europe. Major attempts have been made to do so but they have failed for many different reasons. We are not that far off what the UK does. Sometimes we are ahead and sometimes it is ahead. I do not think there are too many more specific points. The more general point is the issue on confidence in vaccines, which will not be debated before the committee goes to its important meeting.